FHIR IG analytics14,182 resources
Start Prev Rows 2800 - 3000 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.816.json | Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum) | active | 2024-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.818.json | Measles (Tests for measles virus IgG Antibody [Ratio] in Serum) | active | 2025-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.820.json | Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum) | active | 2024-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.822.json | Pneumoconiosis (Unspecified) (ICD10CM) | active | 2023-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.823.json | Pneumoconiosis (Unspecified) (SNOMED) | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.824.json | Computerized Tomography of Chest (Imaging) | active | 2023-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.830.json | Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen) | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.835.json | Lead in Blood (Disorders) (ICD10CM) | active | 2023-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.836.json | Lead in Blood (Disorders) (SNOMED) | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.839.json | Acid Fast Bacilli (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.841.json | Tuberculosis (Interferon Gamma Release Assays) | active | 2024-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.842.json | Tests by Microscopic Observation in Tissue | active | 2024-06 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.846.json | SARS (Tests for SARS_CoV by Culture and Identification Method) | active | 2024-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.847.json | SARS (Tests for SARS_CoV Nucleic Acid) | active | 2024-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.86.json | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.864.json | Nausea (SNOMED) | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.865.json | Confusion (SNOMED) | active | 2023-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.867.json | Dyspnea (SNOMED) | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.869.json | Loss of Consciousness (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.87.json | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.875.json | SARS (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.878.json | MERS (Tests for MERS_CoV Nucleic Acid) | active | 2023-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.88.json | Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM) | active | 2024-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.881.json | Difficulty Breathing (SNOMED) | active | 2023-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.884.json | Tests by Microscopic Observation in Blood | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.889.json | Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody) | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.892.json | Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain) | active | 2024-06 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.895.json | Rhinorrhea (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.896.json | Tests by Microscopic Observation in Blood Smear | active | 2023-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.897.json | Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody) | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.9.json | Xray of Chest (Imaging) | active | 2024-06 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.90.json | Cough (ICD10CM) | active | 2023-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.902.json | Acute Renal Failure [Unspecified Cause] (ICD10CM) | active | 2024-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.907.json | Arthritis [Unspecified Cause] (SNOMED) | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.91.json | Cough (SNOMED) | active | 2023-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.910.json | Epididymitis [Unspecified Cause] (SNOMED) | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.911.json | Epididymitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.914.json | Osteomyelitis [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.915.json | Osteomyelitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.918.json | Spondylitis [Unspecified Cause] (SNOMED) | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.919.json | Arthritis [Unspecified Cause] (ICD10CM) | active | 2023-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.92.json | Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM) | active | 2023-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.927.json | Thrombocytopenia [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.928.json | Bleeding [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.930.json | ECG Abnormalities [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.931.json | Hematemesis [Unspecified Cause] (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.932.json | Hematemesis [Unspecified Cause] (ICD10CM) | active | 2024-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.934.json | Hematuria [Unspecified Cause] (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.935.json | Hemoptysis (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.937.json | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.942.json | Petechiae [Non Traumatic] (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.952.json | Thrombocytopenia [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.956.json | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.957.json | Regional Lymphadenitis [Including Bubo] (SNOMED) | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.958.json | Regional Lymphadenitis (ICD10CM) | active | 2023-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.965.json | Proteinuria [Unspecified Cause] (ICD10CM) | active | 2023-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.969.json | Proteinuria [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.970.json | Bulbar Weakness (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.971.json | Bulbar Weakness (ICD10CM) | active | 2024-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.976.json | Dysphagia (SNOMED) | active | 2025-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.978.json | Impaired Respiration [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.979.json | Botulism (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.98.json | Shigellosis (Disorders) (SNOMED) | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.989.json | Tests for Mycobacterium species by Culture and Identification Method | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.994.json | Organisms (Tests for Nucleic Acid) | active | 2023-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.998.json | Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid) | active | 2025-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1146.999.json | Chlamydia species (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.109.json | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2023-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.110.json | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.112.json | Pressure Injury Deep Tissue | active | 2024-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.113.json | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2022-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.122.json | Inpatient Falls | active | 2021-06 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.130.json | Anticoagulants for VTE Prophylaxis | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.131.json | Anticoagulants for Indications Other than VTE Prophylaxis | active | 2024-01 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.160.json | Abdominal or Pelvic CT Scan with Contrast | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.163.json | Ultrasound of Lower Extremities | active | 2024-08 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.164.json | Ultrasound of Lower Extremities | active | 2024-08 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.165.json | Ultrasound of Lower Extremities | active | 2024-08 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.171.json | Inpatient Falls | active | 2021-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.183.json | Anti Factor Xa Assay | active | 2024-06 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.187.json | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.188.json | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.190.json | Intra Aortic Balloon Pump | active | 2022-04 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.191.json | Intra Aortic Balloon Pump | active | 2022-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.193.json | Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) | active | 2022-04 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.194.json | Pressure Injury Deep Tissue Diagnoses | active | 2022-04 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.196.json | Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses | active | 2022-04 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.197.json | Present on Admission or Clinically Undetermined | active | 2022-04 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.198.json | Not Present On Admission or Documentation Insufficient to Determine | active | 2022-04 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.1.json | DEXA Dual Energy Xray Absorptiometry, Bone Density | active | 2016-07 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.11.json | Bladder Cancer Staging Ta for Urology Care | active | 2016-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.12.json | Bladder Cancer staging T1 for Urology Care | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.13.json | Bladder Cancer staging Tis for Urology Care | active | 2024-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.15.json | Carcinoma of urinary bladder, superficial | active | 2016-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.16.json | Injection Leuprolide Acetate | active | 2017-08 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.17.json | High grade bladder cancer Ta for Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.18.json | Immunocompromised state for Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.19.json | Systemic chemotherapy for urology care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.2.json | Bladder Cancer in Situ | active | 2016-07 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.20.json | Corticosteroids for patients receiving Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.21.json | Calcineurin inhibitors for patients receiving Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.23.json | Immunomodulators for patients undergoing Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.24.json | Monoclonal antibody for patient undergoing Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.28.json | Radiotherapy for patients undergoing Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.29.json | Plasmacytoid cell, morphologic abnormality for urology care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.3.json | Bladder Cancer in Situ | active | 2024-02 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.30.json | Sarcomatoid, morphologic abnormality for Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.31.json | Micropapillary, morphologic abnormality, for Urology Care | active | 2017-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.32.json | Immunosuppressive Drugs for Urology Care | active | 2024-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.38.json | DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care | active | 2017-08 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.39.json | Mixed histology urothelial cell carcinoma for Urology Care | active | 2023-02 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.4.json | BCG Bacillus Calmette Guerin, Tice | active | 2016-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.40.json | Cystectomy for Urology Care | active | 2017-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.44.json | Unavailability of Bacillus Calmette Guerin for urology care | active | 2017-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.45.json | Bladder Cancer for Urology Care | active | 2017-03 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.48.json | Androgen deprivation therapy for Urology Care | active | 2021-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.5.json | BCG Bacillus Calmette Guerin, Connaught | active | 2016-07 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.52.json | BCG Bacillus Calmette Guerin for Urology Care | active | 2020-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.53.json | Cystectomy for Urology Care | active | 2018-04 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.54.json | Acute Tuberculosis for Urology Care | active | 2018-04 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.55.json | Cystectomy for Urology Care | active | 2022-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.56.json | Active Tuberculosis for Urology Care | active | 2018-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.57.json | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.58.json | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.59.json | Hospital Services for Urology | active | 2023-02 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.6.json | Peripheral DXA Scan | active | 2016-07 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.60.json | Chemotherapy Agents for Advanced Cancer | active | 2024-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.8.json | Tuberculosis Diagnosis Prior to Urology Care | active | 2016-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.9.json | Leukemia Diagnosis Prior to Urology Care | active | 2016-07 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.13.json | Preventative Clinical Encounters | active | 2025-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.14.json | Intensive Lifestyle Interventions | active | 2023-01 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.15.json | Intensive Lifestyle Interventions | active | 2023-01 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.16.json | Intensive Lifestyle Interventions | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.17.json | Intensive lifestyle interventions | active | 2023-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.21.json | Outpatient Clinical Encounters | active | 2025-03 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.22.json | Outpatient Clinical Encounters | active | 2025-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.23.json | Outpatient Clinical Encounters | active | 2025-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.24.json | Outpatient Clinical Encounters | active | 2025-03 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.25.json | Reason for No Intensive Lifestyle Intervention | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.27.json | Type 2 Diabetes Diagnoses | active | 2023-01 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.28.json | Type 2 Diabetes Diagnoses | active | 2023-01 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.29.json | Type 2 Diabetes Diagnoses | active | 2023-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.30.json | Prediabetes HbA1c Tests | active | 2023-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.31.json | Prediabetes HbA1c Tests | active | 2023-01 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.32.json | Prediabetes HbA1c Tests | active | 2023-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.33.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.34.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.35.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.36.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.37.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.38.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.4.json | Glycemic Screening Tests | active | 2025-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.40.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.41.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.42.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.43.json | Analgesics for Acute Pain | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.49.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.5.json | Glycemic Screening Tests | active | 2023-01 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.52.json | Remote Physiologic Blood Pressure Monitoring | active | 2024-10 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.57.json | Aldosterone Receptor Blocker for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.58.json | Alpha Blocker for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.59.json | Angiotensin Converting Enzyme Inhibitor for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.6.json | Glycemic Screening Tests | active | 2023-01 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.60.json | Angiotensin II Receptor Blocker for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.61.json | Beta Blocker for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.62.json | Calcium Channel Blocker Dihydropyridine for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.63.json | Calcium Channel Blocker Non Dihydropyridine for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.64.json | Central Acting for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.65.json | Direct Renin Inhibitor for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.66.json | Loop Diuretic for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.67.json | Neuronal Blocking Agent for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.68.json | Potassium Sparing Diuretic for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.69.json | Thiazide Diuretic for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.7.json | Preventative Clinical Encounters | active | 2025-03 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.70.json | Vasodilator for Hypertension | active | 2024-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.73.json | Analgesics for Acute Pain (Non Parenteral Route) | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.74.json | Analgesics for Acute Pain (Parenteral Route) | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.75.json | Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes | active | 2024-11 | hl7 | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.77.json | Antihypertensive Medication Classes | active | 2024-10 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.78.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.79.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.8.json | Preventative Clinical Encounters | active | 2025-03 | hl7 | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.84.json | Renal Colic | active | 2025-04 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.85.json | Renal Colic | active | 2025-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.86.json | Renal Colic | active | 2025-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.88.json | Direct LDL Cholesterol | active | 2025-05 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.89.json | Calculated LDL Cholesterol | active | 2025-05 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.9.json | Preventative Clinical Encounters | active | 2025-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.50.json | Urinary retention | active | 2017-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.51.json | Urinary retention | active | 2017-06 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.52.json | Urinary retention | active | 2017-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.65.json | Morbid Obesity | active | 2018-04 | hl7 | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.66.json | Morbid Obesity | active | 2018-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.67.json | Morbid Obesity | active | 2018-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.68.json | BMI greater than 40 | active | 2019-02 | hl7 | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.69.json | Morbid Obesity | active | 2019-02 | hl7 | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.141.json | Contraceptive Patch SNOMED Devices | active | 2021-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.143.json | Live Birth Delivery CPT Procedures | active | 2024-09 | hl7 | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.144.json | Contraceptive Patch SNOMED Provision Procedures | active | 2021-10 | hl7 | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.145.json | Contraceptive Patch SNOMED Findings | active | 2021-10 | hl7 | sct |